Clinical Trial Update: Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating zonisamide SR plus bupropion SR for obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Bupropion-SR (bupropion)
• Zonisamide SR (zonisamide)

Snippet

Sponsor: Orexigen Therapeutics, Inc | Conditions: Obesity | Phase 2 | Status: COMPLETED